Primary Outcomes for Resuscitation Science Studies A Consensus Statement From the American Heart Association

The guidelines presented in this consensus statement are intended to serve researchers, clinicians, reviewers, and regulators in the selection of the most appropriate primary outcome for a clinical trial of cardiac arrest therapies. The American Heart Association guidelines for the treatment of card...

Full description

Saved in:

Bibliographic Details
Published in:	Circulation (New York, N.Y.) N.Y.), 2011-11, Vol.124 (19), p.2158-2177
Main Authors:	BECKER, Lance B, AUFDERHEIDE, Tom P, MERCHANT, Raina M, O'CONNOR, Robert E, MELTZER, David O, HOLM, Margo B, LONGSTRETH, William T, HALPERIN, Henry R, GEOCADIN, Romergryko G, CALLAWAY, Clifton W, LAZAR, Ronald M, DONNINO, Michael W, NADKARNI, Vinay M, ABELLA, Benjamin S, ADRIE, Christophe, BERG, Robert A
Format:	Article
Language:	eng
Subjects:	American Heart Association Biological and medical sciences Blood and lymphatic vessels Cardiology - standards Cardiology. Vascular system Cardiopulmonary Resuscitation - standards Cardiovascular system Consensus Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Emergency Medical Services - standards Heart Arrest - therapy Humans Medical sciences Pharmacology. Drug treatments United States Vasodilator agents. Cerebral vasodilators
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The guidelines presented in this consensus statement are intended to serve researchers, clinicians, reviewers, and regulators in the selection of the most appropriate primary outcome for a clinical trial of cardiac arrest therapies. The American Heart Association guidelines for the treatment of cardiac arrest depend on high-quality clinical trials, which depend on the selection of a meaningful primary outcome. Because this selection process has been the subject of much controversy, a consensus conference was convened with national and international experts, the National Institutes of Health, and the US Food and Drug Administration. The Research Working Group of the American Heart Association Emergency Cardiovascular Care Committee nominated subject leaders, conference attendees, and writing group members on the basis of their expertise in clinical trials and a diverse perspective of cardiovascular and neurological outcomes (see the online-only Data Supplement). Approval was obtained from the Emergency Cardiovascular Care Committee and the American Heart Association Manuscript Oversight Committee. Preconference position papers were circulated for review; the conference was held; and postconference consensus documents were circulated for review and comments were invited from experts, conference attendees, and writing group members. Discussions focused on (1) when after cardiac arrest the measurement time point should occur; (2) what cardiovascular, neurological, and other physiology should be assessed; and (3) the costs associated with various end points. The final document underwent extensive revision and peer review by the Emergency Cardiovascular Care Committee, the American Heart Association Science Advisory and Coordinating Committee, and oversight committees. There was consensus that no single primary outcome is appropriate for all studies of cardiac arrest. The best outcome measure is the pairing of a time point and physiological condition that will best answer the question under study. Conference participants were asked to assign an outcome to each of 4 hypothetical cases; however, there was not complete agreement on an ideal outcome measure even after extensive discussion and debate. There was general consensus that it is appropriate for earlier studies to enroll fewer patients and to use earlier time points such as return of spontaneous circulation, simple "alive versus dead," hospital mortality, or a hemodynamic parameter. For larger studies, a lo
ISSN:	0009-7322 1524-4539